- 24 Sep 2003
- Olympic News
IOC satisfied with WADA's priorities
The International Olympic Committee discussed during its Executive Board Meeting in Lausanne the key priorities adopted by the Executive Committee of the World Anti-Doping Agency (WADA). The IOC is satisfied that its positions have largely been taken into consideration and that the adopted list of prohibited substances is in accordance with the position of the IOC.
The World Anti-Doping Agency has announced on Tuesday 23 September that its Executive Committee has confirmed the priorities that will define the Agency’s mission in the short and medium term. The Committee has defined implementation of the World Anti-Doping Code, research into doping substances and methods, and education regarding doping issues as the top priorities for WADA in the coming years.
"With these decisions, the Executive Committee has made it clear what WADA's priorities should be in the near future," said WADA President Richard W. Pound. "In responding to our stakeholders' needs, it is clear that we need to give more money to research, do better in educating athletes about the dangers of doping, and monitor whether the Code is being properly implemented."
Funding for out-of-competition testing
While the Committee decided that WADA should continue to be involved in funding anti-doping out-of-competition testing in the near future, it agreed that the bulk of this task should be undertaken by governments, international sports federations and national anti-doping agencies.
List of prohibited substances
The Executive Committee approved the 2004 List of Prohibited Substances and Methods. This is the first time that WADA is solely responsible for the publication of this list. Changes to the list this year include the removal of caffeine and pseudoephedrine. Some substances, such as modafinil, have been added. The complete list will be published on WADA's website by 1 October.
Nine new research projects, focusing on WADA's key priority areas, including blood doping, anabolic steroids and the development of a test for the detection of human growth hormone, were approved by the Committee.
Sanctions for non-payment considered
The Executive Committee was presented with the Agency's draft budget for 2004 and discussed at length measures that could be taken against stakeholders in case of non-payment of WADA dues. To date, WADA has collected less than 63 percent of the contributions owed to it for 2003.
Official website of WADA